ERT Appoints New Associate Director of Business Development - Japan

ERT, a leading provider of centralised ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced the appointment of a new Associate Director of Business Development -
Japan, Miki Stevens. Ms. Stevens will report to the Senior Vice President of Strategic Marketing, Planning and Partnerships. In this new role, Ms. Stevens will work with ERT’s Japanese partner, Site Support Institute (SSI)
to facilitate sales activities and enhanced in-country support of Japanese sponsors and clinical trial sites.

Ms. Stevens has dual Japanese and American citizenships and speaks and writes fluent Japanese and English. She has a Bachelor of Arts degree from Tufts University (Boston) and has built up extensive project management and business development experience, including timeline management, budgeting resource allocation and marketing strategy. Ms. Stevens will assist in all aspects of developing and executing Japanese and other regional Asian strategic initiatives and partnerships working in collaboration with ERT sales, operations and other relevant departments.

Ms Stevens joins ERT from Parexel International Inc (Tokyo) where she worked as an Account Manager in Business Development. In this role, Ms. Stevens managed relations with biopharmaceutical and medical device clients and successfully launched the marketing department. She previously served as a Senior Clinical Research Associate for Ophthalmic Research Associates (Massachusetts, USA), where she was project leader of
clinical trials.

Robert Brown, SVP, Strategic Marketing, Planning and Partnerships at ERT, comments, “We are delighted to welcome Miki to the ERT team. This new appointment continues our investment in the Japanese and wider
Pacific Rim markets helping us to expand our direct sales reach and service the needs of our clients in the best possible way. We strongly believe this appointment will further improve and enhance the quality of our services in this market.”